SLAMF1 Antibody
-
中文名稱：SLAMF1兔多克隆抗體
-
貨號：CSB-PA634321
-
規格：￥1100
-
圖片：
-
Gel: 8%SDS-PAGE, Lysate: 50 μg, Lane: Jurkat cells, Primary antibody: CSB-PA634321(SLAMF1 Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 minute
-
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：
-
別名：4933415F16 antibody; AA177906 antibody; CD 150 antibody; CD150 antibody; CD150 antigen antibody; CDw150 antibody; Estm51 antibody; Ipo 3 antibody; IPO-3 antibody; Ipo3 antibody; MGC151472 antibody; MGC151476 antibody; OTTHUMP00000025670 antibody; OTTHUMP00000060252 antibody; RGD1560634 antibody; Signaling lymphocytic activation molecule antibody; Signaling lymphocytic activation molecule family member 1 antibody; Signaling lymphocytic activation molecule family member 1; isoform CRA_a antibody; Signaling lymphocytic activation molecule family member 1; isoform CRA_b antibody; Signaling lymphocytic activation molecule precursor antibody; Slaf1 antibody; SLAF1_HUMAN antibody; SLAM family; member 1 antibody; Slamf 1 antibody; SLAMF1 antibody; SLAMF1 protein antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Fusion protein of Human SLAMF1
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
抗體亞型：IgG
-
純化方式：Antigen affinity purification
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
-
產品提供形式：Liquid
-
應用范圍：ELISA,WB
-
推薦稀釋比：
Application Recommended Dilution ELISA 1:1000-1:2000 WB 1:200-1:1000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. SLAMF1-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAMF1 signaling seem to exist: one depending on SH2D1A (and perhaps SH2D1B) and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates. Initially it has been proposed that association with SH2D1A prevents binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2. However, signaling is also regulated by SH2D1A which can simultaneously interact with and recruit FYN which subsequently phosphorylates and activates SLAMF1. Mediates IL-2-independent proliferation of activated T-cells during immune responses and induces IFN-gamma production. Downstreaming signaling involves INPP5D, DOK1 and DOK2 leading to inhibited IFN-gamma production in T-cells, and PRKCQ, BCL10 and NFKB1 leading to increased T-cell activation and Th2 cytokine production. Promotes T-cell receptor-induced IL-4 secretion by CD4(+) cells. Inhibits antigen receptor-mediated production of IFN-gamma, but not IL-2, in CD4(-)/CD8(-) T-cells. Required for IL-4 production by germinal centers T follicular helper (T(Fh))cells. May inhibit CD40-induced signal transduction in monocyte-derived dendritic cells. May play a role in allergic responses and may regulate allergen-induced Th2 cytokine and Th1 cytokine secretion. In conjunction with SLAMF6 controls the transition between positive selection and the subsequent expansion and differentiation of the thymocytic natural killer T (NKT) cell lineage. Involved in the peripheral differentiation of indifferent natural killer T (iNKT) cells toward a regulatory NKT2 type. In macrophages involved in down-regulation of IL-12, TNF-alpha and nitric oxide in response to lipopolysaccharide (LPS). In B-cells activates the ERK signaling pathway independently of SH2D1A but implicating both, SYK and INPP5D, and activates Akt signaling dependent on SYK and SH2D1A. In B-cells also activates p38 MAPK and JNK1 and JNK2. In conjunction with CD84/SLAMF5 and SLAMF6 may be a negative regulator of the humoral immune response. Involved in innate immune response against Gram-negative bacteria in macrophages; probably recognizes OmpC and/or OmpF on the bacterial surface, regulates phagosome maturation and recruitment of the PI3K complex II (PI3KC3-C2) leading to accumulation of PdtIns(3)P and NOX2 activity in the phagosomes.; (Microbial infection) Acts as a receptor for Measles virus; also including isoform 4.
-
基因功能參考文獻：
- CD150 and CD180 receptors may modulate transcriptional program in lymphocytic leukemia cells by regulating the transcription factor expression levels PMID: 29284783
- this paper shows that the X-linked lymphoproliferative disease gene product SAP regulates signals induced through the co-receptor SLAM PMID: 28827385
- combination of signals via CD150 and CD180 leads to blocking of pro-survival pathways that may be a restraining factor for neoplastic CLL B cells propagation in more than 50% of CLL cases where these receptors are coexpressed PMID: 28982149
- EBF1 is critical for transcriptional control of SLAMF1 gene in human B cells. PMID: 27424222
- MeV can hijack SLAMF1 to drive endocytosis using a complex pathway that shares features with canonical viral macropinocytosis, phagocytosis, and mechanotransduction. This uptake pathway is specific to SLAMF1-positive cells and occurs within 60 min of viral attachment. PMID: 28100610
- Malignant B-cell lines at the different stages of maturation only partially resemble their normal counterparts by CD150 expression. In malignant B-cell lines, CD150 expression on mRNA level is much broader than on protein level. CD150 isoforms are differentially expressed in normal and malignant B cells with predominant expression of mCD150 isoform. PMID: 27356578
- Data suggest that SLAMF1 is another significant piece in the intricate defective immune-regulatory function of patients with SLE. PMID: 25920347
- results indicate that loss of SLAMF1 expression in chronic lymphocytic leukemia modulates genetic pathways PMID: 26619119
- Upstream open reading frames regulate translation of the long isoform of SLAMF1 mRNA that encodes costimulatory receptor CD150 PMID: 25716736
- Molecular dynamics analysis revealed that mutant R32Q and T53I structures of SAP exhibited structural variation with respect to their backbone atoms before and after binding with the unphosphorylated SLAM peptide. PMID: 24770789
- Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance. PMID: 24373350
- Latent membrane protein 1 was responsible for the CD150 upregulation. PMID: 24238277
- Experimental adaptation of wild-type canine distemper virus (CDV) to the human entry receptor CD150 PMID: 23554862
- conclude that Slamf1 recruits a subset of Vps34-associated proteins, which is involved in membrane fusion and NOX2 regulation PMID: 22493499
- HIV-1 infection induces a high level of SLAM expression on CD4(+) T cells, which may enhance their susceptibility to measles virus and exacerbate measles in coinfected individuals. PMID: 22532682
- the study demonstrates that variants of SLAMF1 and ITLN1, both implicated in inflammation, are associated with type 2 diabetes in Indians. PMID: 22277902
- Subjects previously immunized with measles-mumps-rubella vaccine were genotyped for 66 candidate single nucleotide polymorphisms in the CD46, SLAM and CD209 genes. PMID: 22086389
- The simultaneous interaction of Measles virus glycoprotein-pseudotyped Lentivirus with both CD46 and SLAM is required to achieve efficient and stable transduction of B and T cells. PMID: 21450813
- CD150 receptor could trigger PI3K-mediated Akt signaling pathway in normal, EBV-transformed and malignant B cells. PMID: 21423089
- A role for SLAM in controlling natural killer T (NKT) cell development is consistent with a role in both positive and negative thymic selection of NKT cells in NOD mice. PMID: 21357537
- Our findings suggest that -262A-188G haplotype in the SLAM gene promoter contributes to the risk of systemic lupus erythematosus by increasing the expression of SLAM. PMID: 20810499
- CD150 may contribute to regulation of tumor cell maintenance in low-rate proliferating Hodgkin's lymphoma PMID: 20231852
- Apoptosis of measles virus-infected peripheral blood mononuclear cells is triggered by interaction between viral hemagglutinin protein and cellular receptor, SLAM. PMID: 20618687
- Data show that measles virus infection of alveolar macrophages and subepithelial dendritic cells in the airways precedes infection of lymphocytes in lymphatic organs of mice expressing human SLAM with human-like tissue specificity. PMID: 20042501
- Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: role of Toll stimulators in DC maturation and MV amplification PMID: 12270725
- effect of X-linked lymphoproliferative syndrome gene product SAP/SH2D1A on signaling through signaling lymphocyte activation molecule family of immune receptors PMID: 12458214
- direct correlation between the amount of hSLAM expressed on the cells' surface and the degree of measles virus infection; MV infection induced downregulation of receptor hSLAM and inhibited cell division and proliferation of hSLAM(+)T cells PMID: 12610126
- SLAM mRNA expression in PBMC is modulated during the course of specific immunotherapy, and an early and transient increase of SLAM mRNA expression is associated with clinical symptom improvement PMID: 14657878
- SLAM expression correlates directly with T cell responsiveness to Mycobacterium tuberculosis antigen. PMID: 14707094
- murine Measles virus-infected dendritic cells expressing hSLAM receptor downregulated B7-1, B7-2, CD40, MHC class I, and MHC class II expresssion on their surfaces, increased their rate of apoptosis, and inhibited T-cell proliferation. PMID: 15193925
- binding site with measles virus hemagglutinin: attachment sites for MV receptors SLAM and CD46 overlap on the globular head PMID: 15308701
- CD150 and SH2D1A are coexpressed during a narrow window of B-cell maturation and SH2D1A may be involved in regulation of B-cell differentiation via switching of CD150-mediated signaling pathways. PMID: 15315965
- During ligation of SLAM in leprosy, signaling molecules and transcription factors participate in the induction or reinforcement of interferon-gamma production, promoting cell-mediated immune responses to mycobacterial infection. PMID: 15356162
- activation of peripheral blood cells with agonistic anti-CD3 antibody and exogenous IL-2, as used for generation of cytokine-induced killer cells, results in significant SLAM and SAP activation 5 days after TCR stimulation PMID: 15661039
- We have identified several novel SLAM binding sites at residues 429, 436 and 437 of measles virus haemagglutin (MVH) protein and MVH mutants in these residues dramatically decrease the ability to interaction with the cell surface SLAM. PMID: 16889684
- SNPs present in both the SLAM and CD46 genes are associated with measurable and significant variations in antibody response after measles vaccination PMID: 17560639
- Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP PMID: 17692919
- SLAM and CD46 do not have a role in measles virus growth and syncytium formation in tumor cell lines PMID: 17715217
- Measles virus can infect and produce syncytia in human polarized epithelial cell lines independently of SLAM and CD46 by using distinctive receptor-binding sites on its hemagglutinin. PMID: 18287234
- The functional roles of interleukin-17, SLAM and CREB on IFN-gamma production in persons with tuberculosis are reported. PMID: 19199539
- SLAM contributes to the enhanced immunostimulatory functions of dendritic cells that are observed following the addition of IL-1 in vitro. PMID: 11489980
顯示更多
收起更多
-
亞細胞定位：Cell membrane; Single-pass type I membrane protein.; [Isoform 3]: Secreted.; [Isoform 4]: Cell membrane.
-
組織特異性：Constitutively expressed on peripheral blood memory T-cells, T-cell clones, immature thymocytes and a proportion of B-cells, and is rapidly induced on naive T-cells after activation. Activated B-cells express isoform 1, isoform 3 and a cytoplasmic isoform
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
